Search Results - "Toppmeyer, D."

Immunotherapy combined with chemotherapy and anti-angiogenic therapy for advanced triple-negative breast cancer after multiline failure: a case report and literature review.

Authors: Li, Yilong Chen, Weiwei Zhang, Kaiyuan et al.

Source: Oncologie (De Gruyter). May2026, Vol. 28 Issue 3, p627-632. 6p.

Development and feasibility testing of a conversational chatbot supporting genetic education and testing for hereditary cancer.

Authors: Tundealao S Heidt E Grumet S et al.

Source: Journal of community genetics [J Community Genet] 2026 Jun 22; Vol. 17 (3). Date of Electronic Publication: 2026 Jun 22.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 101551501 Publication Model: Electronic Cited Medium: Print ISSN: 1868-310X (Print) Linking ISSN: 1868310X NLM ISO Abbreviation: J Community Genet Subsets: PubMed not MEDLINE

Multiple Endocrinology Immune-Related Adverse Events (irAEs) Related to Pembrolizumab as Neoadjuvant Treatment in Two Cases of TNBC Patients: Case Reports and Literature Review.

Authors: Ardakani, Khashayar Yazdanpanah Passarella, Gaia Lania, Andrea Gerardo Antonio et al.

Source: Current Oncology. Jan2026, Vol. 31 Issue 1, p28. 16p.

This result is not displayed to guests.
Login for full access.

Expanding access to cancer genetic care for cancer survivors: Rationale and design for a randomized controlled trial of a chatbot-based genetic education and testing.

Authors: An J Huq M Speiser E et al.

Source: Contemporary clinical trials [Contemp Clin Trials] 2026 Mar; Vol. 162, pp. 108217. Date of Electronic Publication: 2026 Jan 17.

Publication Type: Journal Article; Clinical Trial Protocol

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101242342 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-2030 (Electronic) Linking ISSN: 15517144 NLM ISO Abbreviation: Contemp Clin Trials Subsets: MEDLINE

Patterns of Postmastectomy Radiotherapy in Immediate Breast Reconstruction—Results From the iBRA‐2 Cohort Study.

Authors: Rattay, Tim Trickey, Adam O'Connell, Rachel L. et al.

Source: International Journal of Breast Cancer. 5/18/2026, Vol. 2026, p1-10. 10p.

PD-L1-Guided Chemo-Immunotherapy in Advanced Triple-Negative Breast Cancer: A Meta-Analysis of Survival Benefits and Toxicity Profiles.

Authors: Nan, Lingshan Zuo, Xi Yin, Xiaohui et al.

Source: Cancers. May2026, Vol. 18 Issue 9, p1352. 16p.

HLA inherence as a potential parameter in checkpoint inhibitor-associated autoimmune adverse event assessment.

Authors: Gandarillas S Newland ES Toppmeyer D et al.

Source: Frontiers in medicine [Front Med (Lausanne)] 2024 Jan 08; Vol. 10, pp. 1288844. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE

Maintenance low-dose capecitabine versus observation in early-stage triple-negative breast cancer: a randomized controlled trial assessing safety with exploratory survival outcomes.

Authors: Ali, Sarah Hamdy El Nadi, Enas Mohsen Gadallah, Abeer Mokhles et al.

Source: Future Journal of Pharmaceutical Sciences. 4/13/2026, Vol. 12 Issue 1, p1-10. 10p.

Immune-Related Adverse Events in Breast Cancer Patients Who Received Neoadjuvant Chemotherapy with Pembrolizumab: What Needs to Be Managed Before Surgery.

Authors: Lee, Jeeyeon Kang, Byeongju Moon, Joon Suk et al.

Source: Cancers. Mar2026, Vol. 18 Issue 6, p919. 13p.

Romanian Consensus Statement for Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer (HR+/HER2– mBC) and Triple-Negative Metastatic Breast Cancer (mTNBC).

Authors: Median, Mircea Dragoș Antone, Nicoleta Zenovia Volovăț, Simona et al.

Source: Current Oncology. Feb2026, Vol. 31 Issue 2, p120. 25p.

A comparative analysis of Palbociclib and Ribociclib in metastatic hormone receptor-positive, HER2-negative breast cancer: a prospective mid term follow-Up study from an Indian cohort.

Authors: Sreenath, Nihanthy D. Pandalanghat, Suresh Kapoor, Amul et al.

Source: BMC Cancer. 8/18/2025, Vol. 25 Issue 1, p1-9. 9p.

LMP7-Specific Inhibitor M3258 Modulates the Tumor Microenvironment of Triple-Negative Breast Cancer and Inflammatory Breast Cancer.

Authors: Xie, Xuemei Lee, Jangsoon Manyam, Ganiraju C. et al.

Source: Cancers. Jun2025, Vol. 17 Issue 11, p1887. 20p.

Computational Phosphosite-Specific Network Analysis of YES1 Y426 Reveals Cancer-Associated Phosphorylation Patterns.

Authors: Khanum, Afreen Dcunha, Leona Subair, Suhail et al.

Source: Proteomes. Jun2026, Vol. 14 Issue 2, p17. 20p.

Plan Quality Comparison at Five Years in Two Cohorts of Breast Cancer Patients Treated with Helical Tomotherapy.

Authors: Dicuonzo, Samantha Zerella, Maria Alessia Zaffaroni, Mattia et al.

Source: Journal of Clinical Medicine. Mar2025, Vol. 14 Issue 5, p1630. 11p.

Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis.

Authors: Malighetti, Federica Villa, Matteo Villa, Alberto Maria et al.

Source: International Journal of Molecular Sciences. Mar2025, Vol. 26 Issue 5, p1943. 12p.

The MyCancerGene study: a hybrid type 1 effectiveness-implementation randomized study comparing a patient-centered digital genetic health portal to usual care after receipt of cancer genetic testing.

Authors: Chavez-Yenter, Daniel Fetzer, Dominique Egleston, Brian et al.

Source: BMC Cancer. 10/24/2025, Vol. 25 Issue 1, p1-16. 16p.

LIMCH1 inhibits antitumor immunity by upregulating PDL1 in triple-negative breast cancer.

Authors: Qiu, Minghan Gao, Zhanhua Tian, Mengran et al.

Source: Cell Communication & Signaling. 10/8/2025, Vol. 23 Issue 1, p1-18. 18p.

Actinidia eriantha Benth. Root as a New Phytomedicine Inhibits Non-Small Cell Lung Cancer by Regulating·TGF-β/FOXO/mTOR.

Authors: Zhang, Xuan Xiao, Qiyao Chen, Haoran et al.

Source: International Journal of Molecular Sciences. Sep2025, Vol. 26 Issue 18, p8957. 18p.

Multidisciplinary and Tailored Treatment of Locally Advanced Breast Cancer in Progression during Neoadjuvant Chemotherapy: Case Report.

Authors: Cuniolo, Letizia Gipponi, Marco Murelli, Federica et al.

Source: Current Oncology. May2024, Vol. 31 Issue 5, p2856-2866. 11p.